Lunar warns of lower revenues

Bone densitometry vendor Lunar last month announced that its third-quarter revenues would likely decline compared with the same quarter last year. Lunar of Madison, WI, pointed to below-average sales of densitometers in the U.S. and Asia as a reason for the anticipated down quarter (end-March 31).

While the company attributed the dip in Asian sales to the region's recent currency difficulties, U.S. demand has been shifting away from traditional hospital markets toward lower priced systems for physician offices. In an effort to improve access to these emerging markets, Lunar is implementing new distribution channels. The company expects to soon announce new national distributor relationships for its existing physician-office products, as well as its Achilles ultrasound densitometer, which is pending Food and Drug Administration premarket approval.